CDK4 and neoplasm: In terms of mechanism, immune evasion may be associated with the abnormal expression of immune-related regulators, such as IFN-α and IFN-β, and change in tumor microenvironment of CDK4/6 inhibitor–resistant breast tumors (Vijayaraghavan et al., 2017a).